Generation of Antigen-Specific T Cells - Digital Recording (October 16, 2013)
ISCT Webinar: Generation of Antigen-Specific T Cells for Allogeneic Stem Cell Transplant
Presented by the ISCT AUS/NZ Regional Executive Committee
Please open the PDF slides and click the link on the first page to access the Digital Recording.
Date: Wednesday, October 16th in North America/ Thursday, October 17th in Asia and Australia
Time: 6:00pm PT, 8:00pm CT, 9:00pm ET/9:00am Western Australia, 12:00pm Sydney, Australia
Chair: Robert Nordon, PhD, Senior Lecturer, Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia
Speaker(s): Catherine Bollard, MD, FRCPC, Professor of Pediatrics, Children's National Medical Center, Washington D.C., United States and David Gottlieb, MD, Professor of Haematology, Department of Medicine, Westmead Hospital, Westmead, Australia
About the Webinar:
Donor-derived T cells can expand and reconstitute immunity to infection and tumour antigens when given after stem cell transplant. Viral and fungal infections after allogeneic stem cell transplantation are an important cause of morbidity and mortality and early clinical experience suggests that the severity of these can be reduced by administration of antigen specific T cells. Ex vivo generation of antigen-specific T cells requires careful donor selection and adherence to the code of good manufacturing practice in cell generation. This webinar examines technical and clinical progress in the generation and adoptive transfer of multivalent antigen-specific T cells to allogeneic stem cell transplant recipients.